Lucida Medical Ltd ™

We work to find cancer precisely, and fast.

 

With machine learning (ML) and artificial intelligence (AI) methods, combined with an MRI scan, we aim to make cancer screening accurate, accessible, cost-effective, and quick.

Contact Us

Intelligent Early Detection

When we find cancer early, it’s usually easier, safer and less costly to treat. Critically, early detection means that patients have a better outcome.
Having achieved a CE mark for Pi, are currently working to secure further regulatory approvals. While we do this, our products and services are currently for research purposes only, and are not available for sale.

We especially welcome contact from investors and healthcare professionals interested in supporting our research or joining clinical studies.

Latest news:

Lucida Medical announce a Retrospective cohort validation study of AI-based prostate cancer diagnosis support software Pi ™ led by Hampshire Hospitals NHS Foundation Trust (HHNFT) and Lucida Medical

 

 

 

 

 

 

image of a doctor in an operating theatre

Get in touch

To find out more, please contact us through:

Our Partners

We collaborate with Cambridge University, we are a partner in the ReIMAGINE prostate imaging trial, are in the process of establishing collaborative partnerships with several UK NHS Trust hospitals to help further develop and validate and test Pi, our AI system for detecting prostate cancer from MRI.